10 likes | 113 Views
Explore the impact of TPT and ERK2 on cellular signaling pathways in p53-deficient cancer cells, highlighting potential therapeutic strategies.
E N D
wt apaf-1-/- p53-/- Bcl-2 ERK2 C 16 24 48 C 16 24 48 C 16 24 48 TPT (h) Supplemental Figure 3